DOCSLIB.ORG

Advertising (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Advertising (PDF) Introducing TM - @- — @ IODOHIPPURATE0 :.,.@@,123INJECTiON Normal Transp@nt Renogram1 -. HighDetectorEfficiency 0• 9 P9999,9999 lodohippurateSodiumI 131Injection,0.15mCi LowCountRate Low DetectorEfficiency NEPHROFLOWprovidesbettercountingstatisticsandhigherdatadensity. ‘Reference:Dataon file. Medi-Ptiysics, Inc.. Richmond. CA ‘NaHTIftrvstaI . Particularly useful in obstructed patients . Slight advantage in photon intensity . Major advantage in ¼inch crystal efticiency •Imagingshouldbe performedas closeto calibrationtime as possible 744 b4@ 514 41) :so 20 14) IERCENT ABS@RV1I()N ComparisonofI 123andI 131 Characteristic 1123 1131 Modeof Decay Electroncapture Beta Half-Life 13.2hours 193hours PrincipalGamma Energy(keV) 159 364 Intensity 84% 82% Half-Valuelayer,lead,cm 0.037 0.24 DetectionEfficiency: ¼―Nal (TI ) crystal 74.5% 22.5% NEPHROFLOW'@ IODOHIPPURATESODIUMI 123INJECTION Forcomplstspse.cdblng InformationconsultpackagsInsert,abrlefsummaryof whichfollows: DESCRIPTION:IodohippurateSodiumi l23lnjection issupplied asasterile, apyrogenic, Radlopharmaceuticals should be used only by physicians who are qualified by training aqueous,isotonicsalinesolutionfor intravenousadministration.Eachmilliliterof the and experience in the safe use and handling of radsonuclidesand whose experience and solutioncontains37 megabecquerels(1 mtlhcurie)lodohippurateSodiumI 123 at training havebeenapproved bytheapproprlategovemmentagencyauthorizedtollcense calibrationtime, 2 milligramslodohippurateSodium,I percentbenzylalCOhOl(as a the useofradionuclides. preservative). 9 milligrams per milliliter sodium chloride for fsotonfcfty, and up to 0.1 Carc!nogenesls. Mutagenesis, Impairment of Fertility percent ethanol. The solution a buffered with sodium phosphate and the pH a adjusted No long term animal Studies have been performed to evaluate carcinogenic potential. to 7.0-8.5 wIth sodium hydroxide or hydrOchlOricacid. The radionudlidèccomposttion at mutagenicity potential, orwhetherlodohippurate Sodium I 123affectsfertility In males or calibration time is not less than 94.7 percent I 123. not more than 4.8 percent I 124, and not more than 0.5 percent aDothers (1125, I 126, I 130, Na 24. Te 121).The radionuclidic females. composition at expiration time Is not less than 85.5 percent I 123, not more than 12.9 PregnancyCategoryC percent I 124.and not more than I .6 percent all others. AnimalreporductionstudieshavenotbeencOnduCtedwiththisdrug.It Isalsonotknown whether lodohippurate Sodium I 123 can cause fetal harm when administered to a INDICATIONS AND USAGE: lodohippurate Sodium I 123 Injection is a diagnostic aid in determining renal function, renal blood flow. and urinary tractobstructlon, and as a renal pregnant woman, orcan affect reproductivecapaclty. lodohlppurate Sodium I 123should ImagIngagent. be given to a pregnant woman onlyifclearly needed. Ideally, examinations using radlopharmaceuticals. especially those elective In nature. in CONTRAINDICAT1ONS:NoneKnown. women ofchildbearing capabilityshould be performed during thefirst few (approximately WARNINGS: NoneKnown. ten)daysfollowlng the onset of menses. PRECAUTIONS: NursingMothers General Since lodine@123Is excreted in human milk, formula.feedlng should be substituted for The contents of the vial are radioactive. Adequate shieldIng of the preparation must be breast feeding Itthe agent must be administered tothe mother during lactation. maintained at all limes. PediatricUse Do not useaftertheexpiration tlmeanddate(24hoursaftercallbrationtlme)stated on the SafetyandeffectivenessInchildrenhavenotbeenestablished. @bei ADVERSE REACTIONS:Aswlthallorganlciodinecontainingcompounds,thepossibility The prescribed Iodohippurate SodIum I 123 dose should be administered as soon as of allergicreactionsmust be kept In mind. Nausea, vomiting.and faintinghave been practical from the time of receipt of the product (I.e.. as close to calIbration time as reported in conjunction with the administration oflodohippurate Sodium I 123. oossiblallnorderto mlnimlzethefractionotradlatlonexoosure duetorelativeincrease of HOWSUPPLIED: lodohippurateSodiumI 123InjectionIssuppliedinnominal3.5 mlvials as a sterile. nonpyrogenic.aqueous.Isotonicsalinesolutionfor intravenousinjection. Iodohlppurat. Sodium I 123.sawell asotherradloactiv.drugs. mustbe handledwlthcare Eachmlllllltercontains37 megabecquerels(1mIlllcurle)oflodohippurateSodiumI 123at and appropriatesafetymeasuresshouldbe usedto minimizeradiationexposureto calibration time. clinical personnel. Careshouldalsobetakentomlmlnlze radlatlonexposuretothepatient lila available,Inindividualvials,inthefollowlngsizes: conslstentwfth proper Patient management. MPI CatalOgNo.2041;1 mland37 megabcquerels(1 mCI)pervial MPI CatalogNo.2042; 2 mland74megabecquerels(2mCI)pervial Vialsare packagedinIndividualleadshieldswithplasticoutercontainer. CircleReaderServiceNo.1 bIORE FORLESS! RPDIOISOTOPE RECORD Date: Jul 16, 1984 Time 8:11 P.M. Isotope: Tc—99m Sam@ie0 1 Pctivit.tl: 798. mCi Uoiume 28.8 ml Ccnc: 39.9 mCA'ml 99Mo: 27.8 L*:;@ Mo/Tc: .834 uCt'mCi RPDIOISOTOPE RECORD @dte: Jul 16, 1984 @ I re: 8:12 P.M. - . Isovope: Tc-99m Sam@1e 0 Dose: 5.08 inCA Isotope Deca'@Chart COMP-U-CALM8:3e P.M. 38.5 aCi/mi A Puny-Computerized Radioisotope Calibrator .13 ml Mo: .836 uCi'mCA That You and YouxBudget Will Appreciate! 9:@gP.M. 36.3 mC@;m1 .14 ml COMP-U-CALTMGiVESYOUMORE Mo: .@38 uCi/nt@ 9:30 P.M. 34.3 mCi/mi U Providesa printedrecordofdate,time,isotopeactivity, .15 ml concentration. syringe volume and assay results @e4euC@@/A@uCi/mCA U Calculatesand printsoutthe concentrationand volumeforany desireddose, corrected for decay for a whole day, or for a single dose, as desired. Performs complete 99Mo assay on 99!T1Tcsamples. COMP-U-CALTMGiVESYOUMOREFORLESS. ..ONLY$4,9QQ Other Price/Performance Values DELUXE ISOTOPE CAL/PADTMII CALIEI@ATOR Offers a fast. accurate Provides the budget means of measuring the conscious lab with an activity of radioisotope economical calibrator doses. system that's reliable. too. ONLY$3 975 ONLY$ 1,495 nc.To TMVictoreen@ find out how to get more for less, 3541-B.NUCLEARASSOCIATES100%call or write for det@Is. Request Bulletin Divisionof VICTOREEN, INC. SATISFACTION GUARANTEED! iooVOICEROAD Ifforany reason you are not completely satisfiedwith a Nucleai Associates CARLE PLACE, NY 11514-1593 741-6360I JA (516) @ product it may be returned within 30 days of shipment for full credit.VICTOREEN A Subsidiaryof Sheller-Globe THEPPICE/PEPSOPMANCELEADERINRADIOISOTOPECALIBRATORS1 CircleReaderServIceNo.2 IiHP@[email protected]@Iapiapiopio@ Now there is a practical and economical way to meet your \ nuclear medicine requirements. NPI, the originator of Unidose pioneered the way with individual dosages of prescribed radiopharmaceuticals supplied only when you need them. Unidose is only one NPI innovation with the future in mind. No longer must you worry about handling and storing large inventories of radioactive @ materials and waste. You can meet today's demands for cost containment with Unidose. And its safety factor goes a @ long way towards meeting ALARA goals. .‘@ NPI service centers supply your diagnostic imaging needs on demand, 24 hours a day from 47 centralized radiopharmacies nationwide. Quality _@__\ radiopharmaceuticals coupled with NPI'Sradiation safety services and accessory products ensure that future advances in nuclear medicine reach the world of practical application. Meeting your requirements now and for the future, Nuclear Pharmacy Incorporated. I -800-821-0547 4272 Balloon Park Road. NE/Albuquerque, NM 87109 Circle Reader Service No 3 AoouOal..2001 roili0000flde doseoolibrotor XLIVREX.! -i 1 portableXenondelivery andtrappingsystem forusein lungventilation studiesinvolving Xenon133and Xenon127 Circle Reader Service No 5 @ . @. -@-- @1HpIH@IHpIHpIHpIHpIHpIHpIHpIHpIHpIHpIHpIHpIHpIHpIHpIHpIHPInpiHi npI.@@ ,-@ 000leor pharmaov @ :i::@i@ - @ @iih inoorporaled r@ @i;>@ @@JJ @ — @ @‘@—— -@ @: - - .-‘ @ ‘“ NEW PRODUCTS FROM NPI . Call our Toll Free Customer ServIce Number - 1-800-821-0547 AN PEN AND SHUT CASE! The ESP-1Ready To Travel For Emergency Preparedness Or For Health Physicists On the Go Radiation Exposure Surveys •Contamination Surveys Nudear Medicine Applications •RadioactivePackage Surveys Radioactive Waste Monitoring Thecaseabove canbe outfitted with seven possibledetectors forthe followingapplications: . beta detection and contamination surveys . low energy gamma detection •mediurnihigh gamma energy detection •energy compensated garnnia/X-ray detection formeasuring exposure rate We will customizeyour caseto accomodatespecific detector assemblies and detectors of your choice. P.O.Box2108 RepresentedinCanadaby: A DIVISION OF SantaFe,NewMexico87504-2108 SafetySupplyCanada (505)471-3232TWX:910-985-0678214KingStreetEast Eberline Toronto,OntarioM5A1J8 CORPORATION (416)364-3234TELEX065-24390 CircieR@@r Service No.7 . AMR's AccuSync provides Rwave detection with precision and reliability. The finest R-wave Triggering device available for computerized gated cardiac studies. AccuSync5R Features •Isolation Amplifier for Patient Safety. •Digital CR1 Monitor. •ECG Strip Chart Recorder. •Heart Rate/R-R mt. •Trigger Pulse LED. •Trigger Control for Ease of Lead Placement and Precise Location of Trigger Pulse. •R-Trigger Output, Compatible with all Computers. •No Delay. •ECG Output •Playback Mode. (optional) •Event Marker. (optional) •Audio Indicator. FEATURES MODEL All AccuSync-5R features
Load more

Recommended publications
  • Lacrimal Scintigraphy
    LACRIMAL SCINTIGRAPHY Lacrimal Scintigraphy RO Boer, Medical Centre, Alkmaar (Retired) NOTE: no changes have been made since the version of 2007 1. Introduction A standardised volume of 10 μl 99mTc pertechnetate is instilled into the patient’s conjunctival sac using a micro-pipette. In principle, the quantity must be as small as possible, since any increase in the very small tear reservoir can lead to contamination of the eyelids and thus adversely affect the interpretability of the investigation. In contradistinction to the already well-established xray investigation whereby at all times outside influence is exerted on the tear drainage, the aim of this tracer investigation is to study the natural tear drainage. Normally, tears are drained from the conjunctival sac to the lacrimal sac (saccus lacrimalis), then to the naso-lacrimalduct (ductus nasolacrimalis) and finally to the nose and pharynx. 2. Methodology This guideline is based on available scientific literature on the subject, the previous guideline (Aanbevelingen Nucleaire Geneeskunde 2007), international guidelines from EANM and/or SNMMI if available and applicable to the Dutch situation. 3. Indications Epiphora (watering of the eye) is the initial indication. The ability to adequately manipulate the lacrimal pathways in order to improve drainage is closely linked to the indication. This is often achived through surgical procedures such as DCR (dacryocystorhinostomy) or DCP (dacryocystorhinoplasty, ‘angioplasty’ of the lacrimal pathways). Thereafter, the effect of these interventions can be evaluated by means of lacrimal scintigraphy. 4. Relation to other diagnostic procedures The Anel test is performed by cannulating the lower lacrimal point and injecting physiological saline. When the system becomes patent, the patient will taste salt.
    [Show full text]
  • FDA-Approved Radiopharmaceuticals
    Medication Management FDA-approved radiopharmaceuticals This is a current list of all FDA-approved radiopharmaceuticals. USP <825> requires the use of conventionally manufactured drug products (e.g., NDA, ANDA) for Immediate Use. Nuclear medicine practitioners that receive radiopharmaceuticals that originate from sources other than the manufacturers listed in these tables may be using unapproved copies. Radiopharmaceutical Manufacturer Trade names Approved indications in adults (Pediatric use as noted) 1 Carbon-11 choline Various - Indicated for PET imaging of patients with suspected prostate cancer recurrence based upon elevated blood prostate specific antigen (PSA) levels following initial therapy and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging (MRI) to help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation 2 Carbon-14 urea Halyard Health PYtest Detection of gastric urease as an aid in the diagnosis of H.pylori infection in the stomach 3 Copper-64 dotatate Curium Detectnet™ Indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients 4 Fluorine-18 florbetaben Life Molecular Neuraceq™ Indicated for Positron Emission Tomography (PET) imaging of the brain to Imaging estimate β amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) or other causes of cognitive decline 5 Fluorine-18
    [Show full text]
  • Nuclear Medicine
    2013 RSNA (Filtered Schedule) Sunday, December 01, 2013 10:45-12:15 PM • SSA18 • Room: S505AB • Nuclear Medicine (PET/CT in Oncology) 12:30-01:00 PM • CL-NMS-SUA • Room: S503AB • Nuclear Medicine - Sunday Posters and Exhibits (12:30pm - 1:00pm) 01:00-01:30 PM • CL-NMS-SUB • Room: S503AB • Nuclear Medicine - Sunday Posters and Exhibits (1:00pm - 1:30pm) 02:00-03:30 PM • RC111 • Room: S505AB • Multi-modal Imaging Workup for Alzheimer's Disease, Parkinson's Disease, and Related Disorders: Case-based App... Monday, December 02, 2013 08:30-10:00 AM • RC217 • Room: S504CD • PET-MR/Hyperpolarized MR 08:30-12:00 PM • VSNM21 • Room: S505AB • Nuclear Medicine Series: Assessment of Cancer Treatment Response: Updates 12:15-12:45 PM • CL-NMS-MOA • Room: S503AB • Nuclear Medicine - Monday Posters and Exhibits (12:15pm - 12:45pm) 12:45-01:15 PM • CL-NMS-MOB • Room: S503AB • Nuclear Medicine - Monday Posters and Exhibits (12:45pm - 1:15pm) 03:00-04:00 PM • SSE08 • Room: E353C • ISP: Gastrointestinal (Oncology: Staging and Distant Metastases) 03:00-04:00 PM • SSE19 • Room: S504CD • Nuclear Medicine (Quantitative Imaging) 03:00-04:00 PM • SSE20 • Room: S505AB • Nuclear Medicine (SPECT/CT) Tuesday, December 03, 2013 08:30-10:00 AM • MSCC31 • Room: S406A • Case-based Review of Nuclear Medicine: PET/CT Workshop-Head and Neck Cancers (In Conjunction with SNMMI) (An I... 08:30-10:00 AM • RC321 • Room: S102D • Medical Physics 2.0: Nuclear Imaging 08:30-10:00 AM • RC351 • Room: E353C • CT/PET in the Abdomen and Pelvis: How and When (How-to Workshop) (An Interactive Session) 08:30-12:00 PM • VSNM31 • Room: S505AB • Nuclear Medicine Series: Non-FDG PET Radiotracers in Oncology 10:30-12:00 PM • MSCC32 • Room: S406A • Case-based Review of Nuclear Medicine: PET/CT Workshop-Cancers of the Abdomen and Pelvis (In Conjunction with ..
    [Show full text]
  • Dacryocystography: from Theory to Current Practice
    Annals of Anatomy 224 (2019) 33–40 Contents lists available at ScienceDirect Annals of Anatomy jou rnal homepage: www.elsevier.com/locate/aanat SPECIAL ISSUE REVIEW ଝ Dacryocystography: From theory to current practice a,∗ a,b a Swati Singh , Mohammad Javed Ali , Friedrich Paulsen a Institute of Clinical and Functional Anatomy, Friedrich-Alexander University of Erlangen-Nürnberg, Germany b Govindram Seksaria Institute of Dacryology, L.V. Prasad Eye Institute, Hyderabad, India a r t a b i c l e i n f o s t r a c t Article history: Purpose: To provide a review and an update on dacryocystography (DCG) and its relevance in the current Received 11 March 2019 era. Received in revised form 19 March 2019 Methods: The authors performed a PubMed search of all articles published in English on DCG, digital Accepted 20 March 2019 subtraction-DCG (DS-DCG), computed tomographic DCG (CT-DCG) and magnetic resonance-DCG (MR- DCG). Data analyzed include the indications, techniques, interpretations, complication and limitations. Keywords: Results: Dacryocystography has been used for illustrating the morphological and functional aspects of Lacrimal the lacrimal drainage system (LDS). Subtraction DCG provides the precise location of the alterations and Epiphora Dacryocystography acceptably delineates stenosis or an obstruction. Transit time for contrast into the nose varies widely across the studies. Low osmolality iodinated contrast media are tolerated well for DS-DCG and CT-DCG. Subtraction dacryocystography MR dacryocystography However, normal saline either mixed with lidocaine or alone provided similar image quality as obtained CT-DCG with gadolinium for MR-DCG. CT-DCG provides useful information in complex orbitofacial trauma and MR-DCG lacrimal tumors.
    [Show full text]
  • SNMMI Nuclear Medicine Technology Competency Based Curriculum
    Nuclear Medicine Technology Competency- Based Curriculum Guide 5th Edition Introduction Competency-based education in nuclear medicine technology focuses on those elements necessary to become an entry-level nuclear medicine technologist. Emphasizing competencies communicates entry-level knowledge, skills, attitudes, and behaviors that the nuclear medicine technology curriculum must address and that employers can expect of graduates. Competency- based education allows more flexibility in pedagogical approaches to achieve these essential competencies. The competencies are divided into eight sections: 1. Radiation Safety 2. Instrumentation, Quality Control and Quality Assurance 3. Radiopharmacy and Pharmacology 4. Diagnostic and Therapeutic Procedures 5. Patient Care 6. Professionalism and Interpersonal Communication Skills 7. Organization Systems-Based Practice 8. Research Methodology Each section lists the competencies that must be achieved by the entry level nuclear medicine technologist. The rigor of the nuclear medicine technologist entry-level competencies is such that a significant body of knowledge, skills, and experience is necessary to achieve them. This level of rigor is consistent with the Society of Nuclear Medicine and Molecular Imaging—Technologist Section’s (SNMMI-TS) recommendation that the entry-level degree for a nuclear medicine technologist should be at the baccalaureate level. The content listed under the competencies is intended to be used as a guide for what may be included in a program’s curriculum to achieve minimal competency in each area. The specific content listed should be used at the program’s discretion to meet individual curricular and accreditation needs. The content in its entirety is not considered mandatory, and other pedagogies may equally meet each program’s needs.
    [Show full text]
  • Infrequently Performed Studies in Nuclear Medicine: Part 1
    Infrequently Performed Studies in Nuclear Medicine: Part 1 Anita MacDonald and Steven Burrell Department of Diagnostic Radiology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada clinical and technical aspects of each study are discussed, Nuclear medicine is a diverse field with a large number of differ- along with a brief comparison of alternative assessment ent studies spanning virtually all organ systems and medical spe- modalities. Included in Part 1 of this article are dacroscin- cialties. Many nuclear medicine procedures are performed tigraphy, LeVeen shunts, scintimammography, right-to-left routinely; others may be performed only rarely, sometimes less (R-L) shunts, left-to-right (L-R) shunts, and heat-damaged than once per year. The infrequent nature of many studies makes it challenging to retain relevant knowledge and skills. This 2-part red blood cell (RBC) studies. Part 2 will cover cerebral article provides a review of several infrequently performed stud- spinal fluid shunt, brain death, testicular scan, quantitative ies. The topics discussed in Part 1 include dacroscintigraphy, lung perfusion scan, lymphoscintigraphy, and salivary gland LeVeen shunts, scintimammography, right-to-left shunts, left- scintigraphy studies. to-right shunts, and heat-damaged red blood cells. After reading this article, the reader should be able to list and describe the in- DACROSCINTIGRAPHY (LACRIMAL GLAND STUDY) dications for each study, list the doses and describe their proper method of administration, and describe problems that may arise The lacrimal glands are located in the lateral superior during the imaging procedure and how they should be handled. portion of each orbit.
    [Show full text]
  • Financial and Operational Management of Nuclear Medicine Departments in the NHS Within the London Area
    Imagem Sara Raquel Costa Soares Financial and Operational Management of Nuclear Medicine Departments in the NHS within the London Area Dissertação de Mestrado em Gestão e Economia da Saúde, apresentada à Faculdade de Economia da Universidade de Coimbra Orientadora: Drª. Prof. Carlota Quintal Setembro de 2015 Cover (FEUC template) and illustration: Sara Soares Sara Raquel Costa Soares Financial and Operational Management of Nuclear Medicine Departments in the NHS within the London Area Dissertação de Mestrado em Gestão e Economia da Saúde, apresentada à Faculdade de Economia da Universidade de Coimbra para obtenção do grau de Mestre Orientadora: Prof. Doutora Carlota Quintal Coimbra, 2015 Acknowledgments I would like to thank my supervisor, Prof. Drª. Carlota Quintal, for the patient guidance, encouragement and advice she has provided during this last year. I have been extremely lucky to have a supervisor who cared about my work, and who responded to my questions and queries so promptly. I am very grateful for all the interviewees that made this study possible. Without their cooperation and understanding, I would not have learnt so much like I did. I must express my gratitude to Stefan, my boyfriend, for his continued support and encouragement. He must know more about this work than me, after reading it so many times. Sorry for the sleepless nights. I am thankful for the patience of my mother, father and brother who experienced all of the ups and downs of my research. Completing this work would have been all the more difficult were it not for the support and friendship provided by my work colleagues of the Nuclear Medicine department at King´s College Hospital.
    [Show full text]
  • 202158Orig1s000
    &(17(5)25'58*(9$/8$7,21$1' 5(6($5&+ APPLICATION NUMBER: 2ULJV &/,1,&$/3+$50$&2/2*<$1' %,23+$50$&(87,&65(9,(: 6 Clinical Pharmacology Review _ NDA 202-158 Submission Dates January 4, 2013 SDN 1 January 22, 2013 SDN 2 February 15. 2013 SDN 6 June 24, 2013 SDN 12 July 10, 2013 SDN 13 Type/Category Original-1 (Type 5 - New Formulation or New Manufacturer) Brand Name Sodium Pertechnetate Tc99m Injection USP Generic Name Sodium Pertechnetate Tc99m Injection USP Proposed Indication Sodium Pertechnetate Tc99m Injection produced by a TechneGen Generator System is a diagnostic radiopharmaceutical agent intended for use in children and adults for the following indications: Brain Imaging (including cerebral radionuclide angiography) Thyroid Imaging Salivary Gland Imaging Placenta Localization Blood Pool Imaging (including radionuclide angiography) Urinary Bladder Imaging (direct isotopic cystography) for detection of vesico-ureteral reflux. In addition, it is indicated for use in adults for Nasolacrimal Drainage System Imaging (dacryoscintigraphy). Sodium Pertechnetate Tc99m Injection is also used to reconstitute a variety of reagent kits, commonly referred to as Technetium Tc99m Kits, and with each reconstituted kit used for specified diagnostic imaging indications. (b) (4) Dose (depending on indication) Route of Administration Intravenous Injection; oral; instillation in bladder or eyes Applicant Northstar Medical Radioisotopes, LLC 1 Reference ID: 3379891 Reviewing Division Division of Clinical Pharmacology 5 (DCP 5) Medical Division Division of Medical Imaging Products (DMIP) Primary Reviewer Christy S. John, Ph.D. Secondary Reviewer Gene Williams, Ph.D. _ Table of Contents Page Cover Page 1 Table of Contents 2 1.
    [Show full text]
  • Development of a Radiochemistry Laboratory for the Production of Tc-99M Using Neutron Activation
    AC 2007-620: DEVELOPMENT OF A RADIOCHEMISTRY LABORATORY FOR THE PRODUCTION OF TC-99M USING NEUTRON ACTIVATION Sheldon Landsberger, University of Texas-Austin Dr. Sheldon Landsberger is the Coordinator of the Nuclear and Radiation Engineering Program at the University of Texas at Austin and teaches a graduate course in Nuclear and Radiochemistry. Jessica Rosinski, University of Texas-Austin Paul Buckley, Lewis-Clark State College Dan Dugan, Washington State University James Elliston, Washington State University Roy Filby, Washigton State University Jeremy Lessman, Washington State University Alena Paulenova, Oregon State University Page 12.519.1 Page © American Society for Engineering Education, 2007 DEVELOPMENT OF A RADIOCHEMISTRY LABORATORY FOR THE PRODUCTION OF 99m Tc USING NEUTRON ACTIVATION Abstract Many health care professionals increasingly rely on the use of radiopharmaceuticals in diagnosis and therapy. 99m Tc is the world’s most widely used radioisotope in nuclear diagnostic imaging. A small amount of 99m Tc is incorporated in a carrier molecule and injected into the patient’s blood stream which is then used for imaging. Selective accumulation of the 99m Tc in specifically targeted internal organs is achieved through the design of the carrier molecule. Traditionally it is produced from fission of uranium to produce 99 Mo which then decays to 99m Tc. The goal of this work is to set up a comprehensive graduate radiochemistry laboratory to isolate 99m Tc using the neutron activation of stable ammonium molybdenate. Included in the laboratory is an overview of the nuclear medicine information of 99m Tc, the radiation dose received for specific medical diagnoses, and the construction of an efficiency curve for a germanium detector that can be used for activity measurements of other medical isotopes produced.
    [Show full text]
  • Evaluation of Lacrimal Drainage System by Radionuclide Original Article Dacryoscintigraphy in Patients with Epiphora
    Evaluation of lacrimal drainage system by radionuclide Article Original dacryoscintigraphy in patients with epiphora Sagili Chandrasekhara Reddy1, 2, Ahmad Zakaria3, Venkata Muralikrishna Bhavaraju3 1 Department of Ophthalmology, School of Medical Sciences, University Sains Malaysia, Kubang Kerian, Kelantan, Malaysia 2Department of Ophthalmology, Faculty of Medicine and Defence Health, National Defence University of Malaysia, Kem Sungai Besi, Kuala Lumpur, Malaysia 3Department of Nuclear Medicine, Radiotherapy and Oncology, School of Medical Sciences, University Sains Malaysia, Kubang Kerian, Kelantan, Malaysia (Received 4 August 2015, Revised 6 November 2015, Accepted 8 November 2015) ABSTRACT Introduction: This study was done to determine the site of obstruction in lacrimal drainage system in Asian patients suffering from epiphora and to determine the transit time taken for the tracer material to reach the lacrimal sac and the nasal cavity. Methods: Dacryoscintigraphy was performed using radionuclide technetium-99m pertechnetate (99mTc) in 34 patients suffering from unilateral or bilateral epiphora and in 3 cases of post-operative dacryocystorhinostomy. The site of obstruction was noted during the dynamic scintigraphy procedure. The time taken for the tracer material to reach the lacrimal sac in all the eyes and the nasal cavity in the eyes with patency of nasolacrimal duct was determined. Results: Complete obstruction of nasolacrimal duct (NLD) was noted in all 22 unilateral cases. However, in 4 of the contralateral asymptomatic eyes in these patients complete obstruction of NLD was detected. Out of 12 bilateral cases, complete obstruction of NLD was noted in both eyes in 4 cases, and in one eye only in 8 cases. There was partial obstruction of NLD in the other eye in these 8 patients.
    [Show full text]
  • In Evaluation of Tear Drainage System by Dacryoscintigraphy
    Nuclear Medicine Review 2018, 21, 2: 75–78 DOI: 10.5603/NMR.a2018.0021 Copyright © 2018 Via Medica Original ISSN 1506–9680 The role of “after washing imaging” in evaluation of tear drainage system by dacryoscintigraphy Toktam Massoudi, Hamed Shayegani, Ramin Sadeghi Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran [Received 6 II 2018; Accepted 4 IV 2018] Abstract BACKGROUND: The aim of this study was to evaluate the efficacy of “after washing” imaging in interpretation of dacryoscin- tigraphy as a functional imaging technique used in evaluation of tearing problems. MATERIALS AND METHODS: 300 nasolacrimal systems were studied. 100 µCi of technetium-99m sodium pertechnetate as drops of activity (10 µL) were placed into the inferior fornix of each eye. Dynamic images were obtained for 15 minutes in the sitting position. “After washing” phase was done by placing a drop (10 µL) of normal saline in each eye and external ocular massage for an additional 10 minutes. The imaging patterns for each eye in the first dynamic phase and after washing phase were recorded, separately. RESULTS: First dynamic phase demonstrated a sensitivity of 97.4% and specificity of 22.6%. After washing phase showed a sensitivity of 91.2% and specificity 75.5%. After washing test, the obstruction pattern changed to “patent nasolacrimal duct” or “further progression” of the radiotracer to the nasolacrimal duct in the 25.1% and 24.4% of the nasolacrimal systems, respectively. CONCLUSIONS: After washing imaging is a useful method in dacryoscintigraphy which can improve the specificity of scan for diagnosis of lacrimal duct obstruction.
    [Show full text]
  • Clinical Applications of Nuclear Medicine
    Chapter 3 Clinical Applications of Nuclear Medicine Sonia Marta Moriguchi, Kátia Hiromoto Koga, Paulo Henrique Alves Togni and Marcelo José dos Santos Additional information is available at the end of the chapter http://dx.doi.org/10.5772/53029 1. Introduction Nuclear Medicine is a medical specialty in which radioactive substances are used for diag‐ nostic and therapeutic purposes. Historically, its major development occurred after the Sec‐ ond World War. After the attack on Pearl Harbor, the United States developed nuclear reactors to produce atomic bombs, which were subsequently dropped on the Japanese cities of Hiroshima and Nagasaki. After the end of the war, the United States was involved in the campaign for application of Atomic Energy for Peace, which stimulated implementation of knowledge of nuclear energy for medical applications, among other beneficial actions. There is no doubt that this was the greatest advance in the production and distribution of radionu‐ clides for medical purposes. The first radionuclide for medical applications was iodine-131, and this was followed by several others. Artificial production of technetium for diagnostic purposes was a milestone in the history of nuclear medicine. Today, this radioisotope is used the one most for producing imaging. In the beginning, the images were documented using rectilinear scanner and subsequently using scintillation cameras or so-called gamma cameras, with images of poor definition. With technological development, improvements to gamma cameras became possible. The acquisition of functional images, which had previously only been done on a two-dimension‐ al plane, became tomographic with three-dimensional reconstruction. This was named Sin‐ gle-Photon Emission Computed Tomography (known as SPECT), and it increased the sensitivity of detecting abnormalities or lesions.
    [Show full text]